Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets

This article was originally published by Antti Jekunen in Drug Des Devel Ther. 2014; 8: 2009–2016 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract Decision-making is a core function…
The post Decision-makin…


Biobetters, Supergenerics Hold Many Advantages for Pharma Companies

By Larry Ramer, DrugPatentWatch writer A growing number of pharmaceutical companies are looking to simultaneously benefit from the low costs of developing generic treatments and the increased market share and…
The post Biobetters, Supergenerics H…


Drugs and Devices: Comparison of European and U.S. Approval Processes

This paper was originally published by Gail A.Van Norman, MD, in JACC: Basic to Translational Science Volume 1, Issue 5, August 2016, Pages 399-412 under a Creative Commons license. Summary The…
The post Drugs and Devices: Comparison of European …


8 Applications of Machine Learning in The Pharmaceutical Industry

By Pankaj Mondal, DrugPatentWatch writer Machine learning, the most fundamental form of artificial intelligence, has started infiltrating the medical field, and it seems machines can play a crucial role in…
The post 8 Applications of Machine Lear…


FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…
The post FDA Pushes to Reduce Single-Source Generics, I…


When should you outsource drug development

For pharmaceutical companies in flux, contract services are playing a pivotal and more diverse role in the drug development process. The rapid growth of the contract research organization or CRO…
The post When should you outsource drug developmen…


New patent expiration for Pf Prism drug BOSULIF

Annual Drug Patent Expirations for BOSULIF Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five…
The post New patent expiration for Pf Prism drug BOSULIF appeared first on DrugPa…


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…


Which pharmaceutical drugs have the most drug patents in Austria?

This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in A…


Is importing drugs a risky affair?

The FDA was established to ensure the safety of food and medicines sold in the US. Sadly, the original charter is now slowly being affected by the advocates of drug…
The post Is importing drugs a risky affair? appeared first on DrugPatentWatch.


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: